D. Turci

Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial

Alessandro Passardi, Oriana Nanni, Davide Tassinari et al. · Annals of Oncology · 2015 · 157 citations · Full text

Medicine, Oncology, Pharmacology +9

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

Elena Verzoni, Giacomo Cartenì, Enrico Cortesi et al. · Journal for ImmunoTherapy of Cancer · 2019 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17

Use of nivolumab in elderly patients with advanced squamous non–small-cell lung cancer: results from the Italian cohort of an expanded access programme

Francesco Grossi, Lucio Crinò, Antonio Logroscino et al. · European Journal of Cancer · 2018 · 111 citations

Medicine, Geriatric Medicine, Oncology +13

Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial

Roberto Labianca, Alberto F. Sobrero, L. Isa et al. · Annals of Oncology · 2010 · 108 citations · Full text

Medicine, Oncology, Chemotherapy +8

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +10